CARI Management of Cholesterol-Lowering Therapy for People with Chronic Kidney Disease Guideline Summary - Guideline Central

Document Overview

Document Title
Management of Cholesterol-Lowering Therapy for People with Chronic Kidney Disease
Authoring Society

Caring for Australian and New Zealanders with Kidney Impairment

Document Publication Date
Dec 9, 2023
Page Last Reviewed/Updated
May 6, 2026
Document Type
Guideline
Country of Publication
Australia & New Zealand
Full Text Freely Available
Yes
Full Text Guideline
app.magicapp.org/#/guideline/EgJmpn
Source Citation

Cashmore B, Tunnicliffe DJ, Palmer S, Blythen L, Boag J, Kostner K, Krishnasamy R, Lambert K, Miller A, Mullan J, Patu M, Phoon RKS, Rix L, Trompf N, Johnson DW, Walker R; CARI Guidelines Steering Committee. Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap. Nephrology (Carlton). 2024 Aug;29(8):495-509. doi: 10.1111/nep.14295. Epub 2024 Apr 29. PMID: 38684481.

Document Scope, Criteria, and Use Cases

Document Objectives

The objective of this guideline is to review the evidence of lipid lowering therapy and provide recommendations for clinical care regarding use of statin therapy with or without and ezetimibe in adults with chronic kidney disease (CKD).

Scope
Management, Prevention
Diseases/Conditions (MeSH)

D051436 - Renal Insufficiency, Chronic

D057847 - Lipid Regulating Agents

D051436 - Renal Insufficiency, Chronic

D057847 - Lipid Regulating Agents

Keywords
cholesterol-lowering therapy, chronic kidney disease
Target Patient Population
Adults with chronic kidney disease
Target Provider Population
Nephrologist, primary care physician, cardiologist, endocrinologist, dietitian
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.